| |
|
|
|
Therapix Biosciences Ltd.  
|
|
2.5 -0.8 (-0.24%) |
05-24 16:00 |
|
Open: |
3.28 |
Pre close: |
3.3 |
Target:
|
3.60 
|
|
High: |
3.28 |
Low: |
2.41 |
Resistance:
|
3.08
3.50
|
|
Volume: |
121,027 |
Market Cap: |
10M |
Support:
|
2.41
2.01
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.13
|
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
3.31 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
3.78 |
Stochastic Oscillator |
%K(14,3):
|
29.47 |
|
MA(250): |
4.37 |
%D(3): |
37.14 |
|
Average Volume(K) |
3-Month: |
3483
|
52-Week |
High:
|
9.30 |
|
10-Days: |
2520 |
Low: |
2.41 |
|
RSI |
RSI(14):
|
21.43 |
Change(%): |
-41.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-114.0 |
Shares Out. (M) |
3.50 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-96.8 |
Shares Float (M) |
3.50 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.50 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.420 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.84 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.80 |
P/CF |
-1.50 |
|
|
|
|
|
|
